Tag: CureVac
Curevac is reducing staff – economy
The Tübingen biotech company Curevac wants to cut around 150 jobs through a volunteer program. The program has started and will now run for the next few weeks, a spokeswoman…
NASDAQ value CureVac share falls by over 30 percent: CureVac suffers a setback in the vaccine patent dispute with BioNTech
The Federal Patent Court has declared a basic corona vaccine patent from the Tübingen pharmaceutical company CureVac invalid. The shares of the Tübingen company CureVac then lost a good third…
Corona vaccine: Biontech wins in court against Curevac – Economy
The biotech company Curevac has suffered a setback in the patent dispute with its rival Biontech. On Tuesday, the Federal Patent Court declared a Europe-wide basic patent for mRNA vaccines…
CureVac suffers defeat in patent dispute with BioNTech
As of: December 19, 2023 4:42 p.m The biotech company CureVac has suffered a setback in the patent dispute with rival BioNTech. The Federal Patent Court declared a vaccine patent…
Nest protection: Only corona vaccinations during pregnancy help babies
High nest protection when mothers during the pregnancy receive a booster vaccination A comparison of both groups – children whose mothers had received vaccination doses either before or during pregnancy…
Corona vaccine: Curevac and Biontech fight over intellectual property – economy
There is patent EP 1 857 122 B1. The biotechnology company Curevac from Tübingen applied for it at the European Patent Office long before Biontech, the company from Mainz, was…
CureVac share plummets on NASDAQ: CureVac increases operating loss 08/17/2023
The biotech company CureVac is still struggling with burdens from the failed development of a corona vaccine. The operating loss amounted to 132.2 million euros in the first six months,…
Biotechnology – Sanofi manager becomes new Curevac boss – economy
The Tübingen biotech company Curevac is getting a new CEO. Sanofi manager Alexander Zehnder will replace Franz-Werner Haas on April 1 after three years at the helm of the company.…
CureVac vs. BioNTech: Pioneer or Bad Loser?
Status: 07/14/2022 08:12 a.m CureVac was once considered a beacon of hope – but BioNTech won the race for the mRNA vaccine against Covid-19. CureVac is now accusing the competitor…
Corona vaccine: Curevac is suing Biontech for patent infringement
The lawsuit comes late, but it is tough: The biopharmaceutical company Curevac from Tübingen is suing the vaccine manufacturer Biontech, whose vaccine against the corona virus has brought the Mainz-based…